Literature DB >> 31776741

Diagnostic performance of MR imaging in evaluating prognostic factors in patients with cervical cancer: a meta-analysis.

Meiling Xiao1, Bicong Yan1, Ying Li1, Jingjing Lu1, Jinwei Qiang2.   

Abstract

OBJECTIVES: This study aims to determine the diagnostic performance of conventional magnetic resonance imaging (MRI) in assessing the distance between the tumor and the internal os, stromal infiltration, lymph node metastasis, and parametrial invasion in patients with cervical cancer.
METHODS: A systematic English-language literature search of conventional MRI in the evaluation of human cervical cancer was performed in the PubMed, Cochrane Library, Embase, and Web of Science databases from 1995 to 2018. The pooled sensitivity, specificity, diagnostic odds ratio (DOR), and positive and negative likelihood ratios (PLR and NLR) of all studies were calculated. The results were then plotted in a hierarchical summary receiver operating characteristic (HSROC) plot, and meta-regression and subgroup analyses of the parametrial invasion were also performed.
RESULTS: The pooled sensitivity, specificity, DOR, PLR, and NLR were 86%, 97%, 167.91, 24.74, and 0.15, respectively, in evaluating the internal os involvement (6 studies, 454 patients); 87%, 91%, 73.41, 10.22, and 0.14, respectively, in evaluating the stromal infiltration (11 studies, 672 patients); 51%, 89%, 8.63, 4.72, and 0.55, respectively, in evaluating the lymph node metastasis (15 studies, 997 patients); and 75%, 92%, 34.01, 9.38, and 0.28, respectively, in evaluating the parametrial invasion (19 studies, 1748 patients). The meta-regression of the parametrial invasion showed that the application of contrast enhancement was a significant factor affected the heterogeneity (p = 0.039).
CONCLUSIONS: Conventional MRI can accurately evaluate the distance between the tumor and the internal os, as well as stromal infiltration, and performs well in diagnosing the parametrial invasion. However, this method exhibited a limited ability in diagnosing the lymph node metastasis. KEY POINTS: • MRI can help clinicians to accurately assess the distance between the tumor and the internal os, stromal infiltration, and parametrial invasion in patients with uterine cervical neoplasms. • MRI exhibits a limited ability in diagnosing the lymph node metastasis. • Management of patients with uterine cervical neoplasms becomes more appropriate.

Entities:  

Keywords:  Cervical cancer; Lymph node metastasis; Magnetic resonance imaging; Meta-analysis; Parametrial invasion

Mesh:

Year:  2019        PMID: 31776741     DOI: 10.1007/s00330-019-06461-9

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  8 in total

1.  Staging, recurrence and follow-up of uterine cervical cancer using MRI: Updated Guidelines of the European Society of Urogenital Radiology after revised FIGO staging 2018.

Authors:  Lucia Manganaro; Yulia Lakhman; Nishat Bharwani; Benedetta Gui; Silvia Gigli; Valeria Vinci; Stefania Rizzo; Aki Kido; Teresa Margarida Cunha; Evis Sala; Andrea Rockall; Rosemarie Forstner; Stephanie Nougaret
Journal:  Eur Radiol       Date:  2021-04-14       Impact factor: 5.315

Review 2.  Surgical Staging of Locally Advanced Cervical Cancer: Current Status and Research Progress.

Authors:  He Zhang; Weimin Kong; Shuning Chen; Xiaoling Zhao; Dan Luo; Yunkai Xie
Journal:  Front Oncol       Date:  2022-07-06       Impact factor: 5.738

Review 3.  Implications of the new FIGO staging and the role of imaging in cervical cancer.

Authors:  Aki Kido; Yuji Nakamoto
Journal:  Br J Radiol       Date:  2021-05-14       Impact factor: 3.629

4.  Diagnostic Value of 18F-FDG PET/MRI for Revised 2018 FIGO Staging in Patients with Cervical Cancer.

Authors:  Hideaki Tsuyoshi; Tetsuya Tsujikawa; Shizuka Yamada; Hidehiko Okazawa; Yoshio Yoshida
Journal:  Diagnostics (Basel)       Date:  2021-01-29

5.  Region-specific Risk Factors for Pelvic Lymph Node Metastasis in Patients with Stage IB1 Cervical Cancer.

Authors:  Jing Zhao; Jing Cai; Hongbo Wang; Weihong Dong; Yuan Zhang; Shaohai Wang; Xiaoqi He; Si Sun; Yuhui Huang; Bangxing Huang; Kay C Willborn; Ping Jiang; Zehua Wang
Journal:  J Cancer       Date:  2021-03-05       Impact factor: 4.207

6.  Diagnosis Value of Colposcope Combined with Serum Squamous Cell Carcinoma Antigen, Carbohydrate Antigen 125, and Carcinoembryonic Antigen for Moderate to Advanced Cervical Cancer Patients Treated with Modified Fuzheng Peiyuan Decoction.

Authors:  Huijuan Meng; Yulan Zhang; Youguo Chen
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-31       Impact factor: 2.629

7.  Value of diffusion-weighted imaging in preoperative evaluation and prediction of postoperative supplementary therapy for patients with cervical cancer.

Authors:  Liying Liu; Shuo Wang; Tao Yu; Haoyan Bai; Jingyu Liu; Danbo Wang; Yahong Luo
Journal:  Ann Transl Med       Date:  2022-01

8.  Comparative analysis of the value of amide proton transfer-weighted imaging and diffusion kurtosis imaging in evaluating the histological grade of cervical squamous carcinoma.

Authors:  Mengyan Hou; Kai Song; Jipeng Ren; Kaiyu Wang; Jinxia Guo; Yongchao Niu; Zhenyu Li; Dongming Han
Journal:  BMC Cancer       Date:  2022-01-20       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.